Akèy › Kat vèt › Asklepios BioPharmaceutical, Inc.
Asklepios BioPharmaceutical, Inc.: sponso kat vèt (PERM)
Asklepios BioPharmaceutical, Inc. te depoze 3 aplikasyon sètifikasyon travay PERM ki te pran desizyon pandan ane fiskal 2024–2026; sètifye: 3. Mwayèn salè yo ofri $109,600; mwayèn tan soti nan depozisyon jiska sètifikasyon: 476 jou.
Aplikasyon PERM3
Sètifye3
Salè medyan ofri$109,600
Mwayèn jou pou sètifikasyon476
Deja ap travay pou anplwayè a100%
Anplwaye (jan yo depoze)313
Nan biznis depi2001
Adrès anplwayèResearch Triangle Park, NC
Salè H-1B nan Asklepios BioPharmaceutical, Inc. →
Tit travay
| Tit travay | Aplikasyon PERM | Salè medyan |
|---|---|---|
| Scientist, Upstream Process Development (Ref: 6008) | 1 | $103,000 |
| Scientist III - Group Lead | 1 | $109,600 |
| Sr. Scientist, Upstream Process Development (Ref: 6005) | 1 | $140,000 |
Kote travay
Okipasyon
Dènye desizyon
| Tit travay | Salè baz | Kote | Soumèt | Deside | Estati | Jou |
|---|---|---|---|---|---|---|
| Scientist III - Group Lead | $109,600–$164,400 | Research Triangle Park, NC | Nov 5, 2024 | Mar 18, 2026 | Sètifye | 498 |
| Scientist, Upstream Process Development (Ref: 6008) | $103,000 | Research Triangle Park, NC | Mar 8, 2024 | Jun 27, 2025 | Sètifye | 476 |
| Sr. Scientist, Upstream Process Development (Ref: 6005) | $140,000 | Research Triangle Park, NC | Jun 16, 2023 | Sep 19, 2024 | Sètifye | 461 |
Salè yo se pi ba nivo salè yo ofri nan chak aplikasyon, konvèti an yon montan anyèl; estatistik yo itilize aplikasyon plen tan ki sètifye. Sètifikasyon PERM se yon etap nan direksyon yon kat vèt; USCIS pran desizyon sou petisyon an. Se pa konsèy legal. Sous: Depatman Travay Etazini, Done Divilgasyon OFLC PERM, ane fiskal 2024–2026 (dènye desizyon Jun 30, 2026).